Locations:
Search
A peptide drug candidate based on a Cleveland Clinic discovery disrupted cancer growth and self-renewal.
Cleveland Clinic has received a "Decision to Grant" notice from the Japan Patent Office for the patent application titled "Ovarian Cancer Vaccines"
Cleveland Clinic portfolio company with innovative technology accurately detects cancer based on analysis of changes to protein structure.
Both studies were designed to evaluate the safety and performance of the Cardiac Pulmonary Nerve Stimulation (CPNS™) System in patients suffering from Acute Decompensated Heart Failure (ADHF).
In the Cleveland Clinic Innovations profile series, members of the Innovations team share their journey to joining the Innovations department at Cleveland Clinic, what they find inspiring about their role and advice for potential inventors.
Competition promotes culture of innovation across Cleveland Clinic.
Cleveland Clinic inventors Amit Bhatt, MD, and John Vargo, MD, share their journey to impacting patient care through innovation.
Prevent Biometrics' technology records head impacts and uses Bluetooth transmission to report linear and angular accelerations and velocities.
Becker's honors 34 hospitals and health systems with forward-thinking innovation programs.
First in-human trial phase one results published in Nature Medicine. The study was also supported by Enspire DBS Therapy, Inc.